PDGF-D/PDGF-ββ Receptor-Regulated Chemotaxis of Malignant Mesothelioma Cells
PDGF-D/PDGF-ββ Receptor-Regulated Chemotaxis of Malignant Mesothelioma Cells
复制标题
DOI:
10.1159/000337605
复制
发表时间:
2012-01-01
影响因子:
--
通讯作者:
Nishizaki, Tomoyuki
中科院分区:
文献类型:
--
作者:
Okada, Asuka;Yaguchi, Takahiro;Nishizaki, Tomoyuki
Background/Aims: Our earlier study suggested that platelet-derived growth factor (PDGF)-beta beta receptor regulates chemotaxis of human malignant mesothelioma cells such as MSTO-211H, NCIH-2052, NCIH-2452, and NCIH-28 cells, but not non-malignant Met5A cells. The present study was designed to gain further insight into the PDGF-beta beta receptor signals underlying the chemotaxis. Methods: PDGF-D secreted from cells, activation of Akt and ERK, and cell migration were monitored for cells with and without knocking-down PDGF-beta beta receptor. Results: FBS significantly stimulated PDGF-D secretion from malignant mesothelioma cells, but not Met5A cells. PDGF-D activated Akt and ERK in both the nonmalignant and malignant cells. PDGF-D significantly facilitated migration of malignant mesothelioma cells, but not Met5A cells, with the extent varying among the cell types. The facilitatory action of PDGF-D was clearly prevented by knocking-down PDGF-beta beta receptor or inhibitors of PI3 kinase, PDK1, Akt, Rac1, ROCK, and MEK. Conclusion: The results of the present study indicate that PDGF-D promotes malignant mesothelioma cell chemotaxis through PDGF-beta beta receptor signaling pathways along a PI3 kinase/PDK1/Akt/Rac1/ROCK axis and relevant to ERK activation. Copyright (C) 2012 S. Karger AG, Basel